pI: 10.4807 |
Length (AA): 157 |
MW (Da): 18101 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | VEG Tachyzoite, ME49 Tachyzoite, ME49 merozoite, ME49 Oocyst, ME49 Bradyzoite. | Gregory Hehl AB Fritz HM Sibley/Greg |
Hehl AB | Asexual expansion of Toxoplasma gondii merozoites is distinct from tachyzoites and entails expression of non-overlapping gene families to attach, invade, and replicate within feline enterocytes. |
Sibley/Greg | ToxoDB |
Fritz HM | Transcriptomic analysis of toxoplasma development reveals many novel functions and structures specific to sporozoites and oocysts. |
Gregory | ToxoDB |
Ortholog group members (OG5_142475)
Species | Accession | Gene Product |
---|---|---|
Babesia bovis | BBOV_II007570 | hypothetical protein |
Neospora caninum | NCLIV_058550 | hypothetical protein, conserved |
Plasmodium berghei | PBANKA_0203750 | phosphatidate cytidylyltransferase, putative |
Plasmodium berghei | PBANKA_0203650 | conserved Plasmodium protein, unknown function |
Plasmodium falciparum | PF3D7_0109850 | phosphatidate cytidylyltransferase, putative |
Plasmodium falciparum | PF3D7_0109950 | conserved Plasmodium protein, unknown function |
Plasmodium knowlesi | PKNH_0203950 | phosphatidate cytidylyltransferase, putative |
Plasmodium knowlesi | PKNH_0203850 | conserved Plasmodium protein, unknown function |
Plasmodium vivax | PVX_081294 | conserved Plasmodium protein, unknown function |
Plasmodium vivax | PVX_081296 | phosphatidate cytidylyltransferase, putative |
Toxoplasma gondii | TGME49_315930 | integral membrane protein, DUF56 family protein, putative |
Theileria parva | TP02_0702 | hypothetical protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
PBANKA_0203650 | Plasmodium berghei | Essential | plasmo |
PBANKA_0203750 | Plasmodium berghei | Essential | plasmo |
TGME49_315930 this record | Toxoplasma gondii | Probably essential | sidik |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.